A detailed history of Advisor Group Holdings, Inc. transactions in Mannkind Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 29,009 shares of MNKD stock, worth $177,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,009
Previous 40,082 27.63%
Holding current value
$177,244
Previous $209,000 12.92%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.01 - $6.7 $55,475 - $74,189
-11,073 Reduced 27.63%
29,009 $182,000
Q2 2024

Aug 13, 2024

SELL
$4.05 - $5.43 $84,033 - $112,667
-20,749 Reduced 34.11%
40,082 $209,000
Q1 2024

May 10, 2024

BUY
$3.25 - $5.27 $4,644 - $7,530
1,429 Added 2.41%
60,831 $275,000
Q4 2023

Feb 12, 2024

SELL
$3.34 - $4.29 $30,303 - $38,923
-9,073 Reduced 13.25%
59,402 $216,000
Q3 2023

Nov 13, 2023

BUY
$3.91 - $5.45 $23,491 - $32,743
6,008 Added 9.62%
68,475 $282,000
Q2 2023

Aug 21, 2023

SELL
$3.72 - $4.79 $171 - $220
-46 Reduced 0.07%
62,467 $254,000
Q2 2023

Aug 10, 2023

SELL
$3.72 - $4.79 $28,714 - $36,974
-7,719 Reduced 10.99%
62,513 $254,000
Q1 2023

May 12, 2023

SELL
$3.95 - $5.63 $16,195 - $23,083
-4,100 Reduced 5.52%
70,232 $287,000
Q4 2022

Feb 10, 2023

BUY
$3.02 - $5.37 $11,569 - $20,572
3,831 Added 5.43%
74,332 $391,000
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $7,774 - $11,309
2,600 Added 3.83%
70,501 $218,000
Q2 2022

Aug 10, 2022

BUY
$2.67 - $4.77 $2,162 - $3,863
810 Added 1.21%
67,901 $263,000
Q1 2022

May 04, 2022

SELL
$2.62 - $4.45 $50,081 - $85,061
-19,115 Reduced 22.17%
67,091 $1.05 Million
Q3 2021

Nov 05, 2021

BUY
$3.89 - $5.48 $1,711 - $2,411
440 Added 0.51%
86,206 $378,000
Q2 2021

Aug 02, 2021

SELL
$3.61 - $5.45 $81,661 - $123,284
-22,621 Reduced 20.87%
85,766 $467,000
Q1 2021

May 13, 2021

BUY
$3.14 - $6.14 $23,832 - $46,602
7,590 Added 7.53%
108,387 $434,000
Q4 2020

Feb 10, 2021

SELL
$1.79 - $4.04 $13,403 - $30,251
-7,488 Reduced 6.92%
100,797 $316,000
Q3 2020

Nov 12, 2020

BUY
$1.56 - $2.08 $9,420 - $12,561
6,039 Added 5.91%
108,285 $196,000
Q2 2020

Aug 14, 2020

BUY
$0.94 - $2.21 $5,978 - $14,055
6,360 Added 6.63%
102,246 $179,000
Q1 2020

May 18, 2020

BUY
$0.84 - $1.76 $80,544 - $168,759
95,886 New
95,886 $94,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.57B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.